HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

DOTALAN

binds tumors, perhaps by binding hsst(2-5); structure in first source
Also Known As:
111In-DOTALAN; 90Y-DOTALAN; DOTA-beta-naphthyl(1)-lanreotide; DOTA-betaNal(1)-lanreotide
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Prostatic Neoplasms (Prostate Cancer)
2. Neoplasms (Cancer)
3. Melanoma (Melanoma, Malignant)
4. Breast Neoplasms (Breast Cancer)
5. Adenocarcinoma